申请人:HUNG David T.
公开号:US20100216814A1
公开(公告)日:2010-08-26
This disclosure is directed to pyrido[4,3-b]indoles having rigid moieties. The compounds in one embodiment are pyrido[4,3-b]indoles having an unsaturated hydrocarbon moiety. The compounds in another embodiment are pyrido[4,3-b]indoles having a cycloalkyl, cycloalkenyl or heterocyclyl moiety. Pharmaceutical compositions comprising the compounds are also provided, as are methods of using the compounds in a variety of therapeutic applications, including the treatment of a cognitive disorder, psychotic disorder, neurotransmitter-mediated disorder and/or a neuronal disorder.
本文揭示了具有刚性基团的吡啶并[4,3-b]吲哚。在一种实施例中,化合物是具有不饱和碳氢基团的吡啶并[4,3-b]吲哚。在另一种实施例中,化合物是具有环烷基,环烯基或杂环基团的吡啶并[4,3-b]吲哚。还提供了包括这些化合物的制药组合物,以及使用这些化合物进行各种治疗应用的方法,包括治疗认知障碍,精神障碍,神经递质介导的障碍和/或神经元障碍。